ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)

$2.99 -0.03 (-0.9934%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) News Sources

NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board

08-07-2026

yahoo.com

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

20-04-2026

yahoo.com

Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money

20-04-2026

yahoo.com

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026

30-04-2026

yahoo.com

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

13-05-2026

yahoo.com

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

27-05-2026

yahoo.com

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

08-06-2026

yahoo.com

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

22-06-2026

yahoo.com

Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial

25-06-2026

yahoo.com

Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights

13-08-2026

yahoo.com

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) Sentiment Trend

0 25 50 75 100 78 74 93 83 90 84 79 68 91 86 08-07-2026 20-04-2026 30-04-2026 13-05-2026 27-05-2026 08-06-2026 22-06-2026 25-06-2026 13-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) FAQs

toggle

What is the current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is $2.99.


toggle

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) absolute price change since previous trading day?

The absolute price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is $-0.03.


toggle

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) percentage price change since previous trading day?

The percentage price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is -0.9934%.


toggle

What is the most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is 83 out of 100.


toggle

What is the most recent average sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The most recent sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is .


SEC-8K** Filing Available For ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.